KPTI - Karyopharm Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $33.86. This is a potential upside of $26.59 (365.75%) from yesterday's end of day stock price of $7.27.

Karyopharm Therapeutics's activity chart (see below) currently has 18 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.25% with an average time for these price targets to be met of 45.71 days.

Highest price target for KPTI is $270, Lowest price target is $15, average price target is $76.2.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 04-Nov-2025. First documented stock forecast 02-Jun-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$19

$13.38 (238.08%)

1 months 18 days ago
(04-Nov-2025)

1/6 (16.67%)

$13.35 (236.28%)

38

Hold

$15

$9.38 (166.90%)

2 months 9 days ago
(13-Oct-2025)

0/1 (0%)

$9.35 (165.49%)

Buy

$270

$264.38 (4704.27%)

$255

2 months 13 days ago
(09-Oct-2025)

0/5 (0%)

$96.15 (55.31%)

Buy

$21

$15.38 (273.67%)

2 months 13 days ago
(09-Oct-2025)

1/1 (100%)

$-152.85 (-87.92%)

1

Buy

$56

$49.99 (831.78%)

$7

9 months 20 days ago
(02-Mar-2025)

1/2 (50%)

$44.41 (383.18%)

12

Show more analysts

Please expand the browser size to see the chart

What is KPTI (Karyopharm Therapeutics) average time for price targets to be met?

On average it took 45.71 days on average for the stock forecasts to be realized with a an average price target met ratio 29.25

Which analyst has the current highest performing score on KPTI (Karyopharm Therapeutics) with a proven track record?

JONATHAN CHANG

Which analyst has the most public recommendations on KPTI (Karyopharm Therapeutics)?

Jonathan Chang has 18 price targets and 12 ratings on KPTI

Which analyst is the currently most bullish on KPTI (Karyopharm Therapeutics)?

Arlinda Lee with highest potential upside - $294.38

Which analyst is the currently most reserved on KPTI (Karyopharm Therapeutics)?

David Lebowitz with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?